Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04601948
Other study ID # 201907702
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 6, 2019
Est. completion date September 4, 2020

Study information

Verified date May 2023
Source University of Iowa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this pilot study is to explore the feasibility, acceptability, and efficacy of a 6-week mobile health (mHealth) physical activity intervention among adolescent and young adult (AYA) cancer survivors being treated at the University of Iowa Hospitals and Clinics.


Description:

The purpose of this pilot study is to explore the feasibility, acceptability, and efficacy of a 6-week mobile health (mHealth) physical activity intervention among adolescent and young adult (AYA) cancer survivors being treated at the University of Iowa Hospitals and Clinics. Eligible participants will receive a Fitbit activity monitor and access to the mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races. AYA cancer survivors between 13-39 years are invited to participate and the impact of this intervention will be tested over 6 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date September 4, 2020
Est. primary completion date September 4, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years to 39 Years
Eligibility Inclusion Criteria: - Male and female cancer survivors - Diagnosed between 13 and 39 years old - Currently 3-24 months post-treatment (or in maintenance therapy) - Receiving survivorship care at HCCC/UIHC - In remission - Physically able to walk without limitations - Own a smartphone with a data plan that is also capable of receiving and sending texts - Able to understand English and provide informed assent/consent Exclusion Criteria: - Physically unable to walk without limitations - Actively receiving cancer treatment - Does not own a smartphone with a data plan - Visual or cognitive impairments causing inability to read, complete or sign the consent form and survey - Participants with diagnosis of thyroid cancer (due to differences in physical, psychological, emotional, and social effects) - Presence of a psychiatric disorder that is not managed/unstable or suicidal ideation/actuation in preceding 12 months - Currently meeting physical activity requirements per American Cancer Society guidelines (150 or more minutes per week of moderate to vigorous physical activity)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
mHealth Activity Intervention
Eligible participants will receive a Fitbit activity monitor and access to our mHealth physical activity intervention for 6 weeks. The intervention will include regular motivational messages to encourage activity, a social media thread to provide social support, and a series of fun virtual walking races.

Locations

Country Name City State
United States University of Iowa Iowa City Iowa

Sponsors (2)

Lead Sponsor Collaborator
Lucas Carr University of Iowa

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of steps taken per day Number of steps taken per day on each day of the intervention Dail steps will be measured each day of the intervention for 7 weeks
Secondary PROMIS Fatigue Scale 8 item scale, lower score is better Change in fatigue over 7 weeks
Secondary PROMISE Pain Scale 8 item scale, lower score is better Change in pain over 7 weeks
Secondary PROMIS Physical Function Scale 8 item scale, lower score is better Change in physical function over 7 weeks
Secondary PROMIS Depression Scale 8 item scale, lower score is better Change in depression over 7 weeks
Secondary PROMIS Anxiety Scale 8 item scale, lower score is better Change in anxiety over 7 weeks
Secondary Exercise Self-Regulatory Efficacy 20 item scale, higher score is better Change in exercise self regulatory efficacy over 7 weeks
Secondary Social Support for exercise 13 item scale, higher score is better Change in social support for exercise over 7 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients